Corrigendum to "Recombinant measles virus encoding the spike protein of SARS-CoV-2 efficiently induces Th1 responses and neutralizing antibodies that block SARS-CoV-2 variants" [Vaccine 41(11) (2023) 1892-1901].

Vaccine

Department of Medical and Biological Sciences, The Catholic University of Korea, Gyeonggi-do, Bucheon, Republic of Korea; BK Plus Department of Biotechnology, The Catholic University of Korea, Gyeonggi-do, Bucheon, Republic of Korea. Electronic address:

Published: November 2023

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11021202	PMC
http://dx.doi.org/10.1016/j.vaccine.2023.10.033	DOI Listing

Publication Analysis

corrigendum "recombinant

"recombinant measles

measles virus

virus encoding

encoding spike

spike protein

protein sars-cov-2

sars-cov-2 efficiently

efficiently induces

induces th1

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!